Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Sep;9(9):1935-9.
doi: 10.3748/wjg.v9.i9.1935.

Apoptosis-inducing effect of recombinant Caspase-3 expressed by constructed eukaryotic vector on gastric cancer cell line SGC7901

Affiliations

Apoptosis-inducing effect of recombinant Caspase-3 expressed by constructed eukaryotic vector on gastric cancer cell line SGC7901

Yuan-Gen Fu et al. World J Gastroenterol. 2003 Sep.

Abstract

Aim: To investigate the apoptosis-inducing effect of Caspases-3 expressed by constructed eukaryotic vector on gastric cancer cell line SGC7901.

Methods: PCR was employed to amplify the sequences of both small and large subunits of Caspases-3. Its products were separately cloned into the Sma I site of pBluescript KS(+) to generate both plasmids pBS/SS and pBS/LS. The small subunit fragment was excised from plasmid pBS/SS with BamH I and then inserted into the BamH I site of plasmid pBS/LS preceding that of the large subunit to yield plasmid pBS/Rev-Caspase-3. Rev-Caspase-3 cDNA was excised with Kpn I+Xba I and then subcloned into plasmid pcDNA3.1 (+) to construct Rev-Caspase-3 eukaryotic expression vector pcDNA/Rev-Caspase-3, which was used to transiently transfect SGC7901 cell line. Cell count, MTT assay and electron microscopy were used to confirm the antiproliferation and apoptosis-inducing effect of Rev-Caspase-3 expression on gastric cancer cells.

Results: Plasmid pBS/Rev-Caspase-3 and eukaryotic expression vector pcDNA/Rev-Caspase-3 were successfully constructed. SGC7901 cells were transiently transfected by either pcDNA/Rev-Caspase-3 or pcDNA3.1 (+) for 24, 48, 72, and 96 h respectively. Cell growth was measured by cell count and MTT assay. In cell count assay, the cell numbers were 1.8 X 10(6), 1.55 X 10(6), 2.0 X 10(6), and 3.1 X 10(6) in the experimental group and 2.5 X 10(6), 3.1 X 10(6), 4.0 X 10(6), and 5.7 X 10(6) in the control group at 24, 48, 72 and 96 h respectively. The growth of SGC7901 cells was suppressed by Rev-Caspase-3 in a time-dependent manner (P<0.05). The results of MTT assay were similar to that of cell count (P<0.05). The characteristics of apoptosis such as chromatin condensation, crescent formation and margination were seen and more obvious with time in the given-experimental period in the experimental group, but not easily observed in the control group.

Conclusion: The expression of Rev-Caspase-3 by the constructed eukaryotic vector can significantly induce apoptosis of gastric cancer cell line SGC7901, which may exhibit a potential way in gastric cancer gene therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic map of constructions of recombinant Caspases-3 and eukaryotic expression plasmid pcDNA/Rev-Caspases-3.
Figure 2
Figure 2
Identification of plasmid pBS/Rev-Caspase-3 by PCR with SS-forward and LS-reverse as primers. M: 100 bp ladder DNA marker, 1: PCR product, 882 bp.
Figure 3
Figure 3
Enzyme digestion analysis of plasmid pcDNA/Rev-Caspase-3. M: 100 bp ladder DNA marker, 1: pcDNA/Rev-Caspase-3 cut with Stu I, 2: pcDNA/Rev-Caspase-3 cut with
Figure 4
Figure 4
Comparison of cell count between SGC7901 cells trans-fected with pcDNA3.1 (+) and pcDNA/Rev. Caspase.
Figure 5
Figure 5
Comparison of MTT assays between SGC7901 cells transfected with pcDNA3.1 (+) and pcDNA/Rev.Caspase-3.
Figure 6
Figure 6
Electron microscopy of SGC7901 cells transfected with pcDNA3.1 (+) or pcDNA/Rev.Caspases-3. A: SGC7901 trans-fected with pcDNA/Rev. Caspases-3. Notice the chromatin condensation, crescent formation, original margination (× 5000); B: SGC7901 transfected with pcDNA3.1 (+), Notice no characteristics of apoptosis (× 5000).

References

    1. Sauer G, Deissler H, Kurzeder C, Kreienberg R. New molecular targets of breast cancer therapy. Strahlenther Onkol. 2002;178:123–133. - PubMed
    1. Castiglioni P, Martin-Fontecha A, Milan G, Tomajer V, Magni F, Michaelsson J, Rugarli C, Rosato A, Bellone M. Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells. Cancer Res. 2002;62:1116–1122. - PubMed
    1. Paczesny S, Beranger S, Salzmann JL, Klatzmann D, Colombo BM. Protection of mice against leukemia after vaccination with bone marrow-derived dendritic cells loaded with apoptotic leukemia cells. Cancer Res. 2001;61:2386–2389. - PubMed
    1. Amin S, Robins RA, Maxwell-Armstrong CA, Scholefield JH, Durrant LG. Vaccine-induced apoptosis: a novel clinical trial end point. Cancer Res. 2000;60:3132–3136. - PubMed
    1. Li HL, Chen DD, Li XH, Zhang HW, Lu YQ, Ye CL, Ren XD. Changes of NF-kB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species. World J Gastroenterol. 2002;8:431–435. - PMC - PubMed